TABLE 2

Affinity estimates (pKI) for PAMs at mGlu5-wt and mutants from inhibition binding assays

Data represent the mean ± S.E.M. of a minimum of three independent determinations.

MutationVU0360172 (Nicotinamide)VU0403602 (Picolinamide)VU0360173 (Nicotinamide)VU0405398 (Picolinamide)VU0415051 (Nicotinamide)VU0405386 (Picolinamide)
R5-wt (low)6.57 ± 0.02#8.26 ± 0.155.12 ± 0.076.05 ± 0.12#6.88 ± 0.04#7.98 ± 0.05#
I650AN.D.7.89 ± 0.105.30 ± 0.266.41 ± 0.146.62 ± 0.117.69 ± 0.15
P742S5.90 ± 0.12*7.24 ± 0.23*5.12 ± 0.275.78 ± 0.146.35 ± 0.13*7.19 ± 0.12*
L743V6.32 ± 0.066.98 ± 0.10*4.86 ± 0.085.71 ± 0.01*6.25 ± 0.17*7.58 ± 0.04
N746A6.22 ± 0.077.49 ± 0.07*4.63 ± 0.105.75 ± 0.036.35 ± 0.26*7.45 ± 0.30
G747V6.76 ± 0.05N.D.N.D.N.D.7.06 ± 0.278.17 ± 0.35
V788A7.08 ± 0.238.70 ± 0.026.10 ± 0.09*7.87 ± 0.05*8.15 ± 0.07*9.20 ± 0.10*
F792A7.06 ± 0.157.85 ± 0.045.68 ± 0.066.74 ± 0.08*7.09 ± 0.067.71 ± 0.19
C815A6.74 ± 0.248.01 ± 0.035.01 ± 0.076.26 ± 0.046.92 ± 0.117.96 ± 0.16
  • N.D., not determined.

  • * P < 0.05 vs. wild-type receptor, one-way analysis of variance (ANOVA), Dunnett’s post-test; #data previously reported (Gregory et al., 2012).